Anaphylaxis associated with omalizumab administration: Risk factors and patient characteristics
Author:
Publisher
Elsevier BV
Reference9 articles.
1. Anaphylactic reactions associated with omalizumab administration: analysis of a case-control study;Lieberman;J Allergy Clin Immunol,2016
2. Delayed onset and protracted progression of anaphylaxis after omalizumab administration in patients with asthma;Limb;J Allergy Clin Immunol,2007
3. Anaphylaxis epidemiology in patients with and patients without asthma: a United Kingdom database review;González-Pérez;J Allergy Clin Immunol,2010
4. Anaphylaxis. A review of 266 cases;Kemp;Arch Intern Med,1995
5. Anaphylaxis: risk factors for recurrence;Mullins;Clin Exp Allergy,2003
Cited by 70 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Identification of the Top 15 Drugs Associated With Anaphylaxis: A Pharmacovigilance Study;Clinical & Experimental Allergy;2025-06-08
2. Bullous pemphigoid: A practical approach to diagnosis and management in the modern era;Journal of the American Academy of Dermatology;2025-06
3. LP‐003, a novel high‐affinity anti‐IgE antibody for inadequately controlled seasonal allergic rhinitis: A multicenter, randomized, double‐blind, placebo‐controlled phase 2 clinical trial;Clinical and Translational Allergy;2025-06
4. Adverse effects of biologics used to treat asthma;Therapeutic Advances in Respiratory Disease;2025-03
5. Omalizumab safety concerns;Journal of Allergy and Clinical Immunology;2025-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.7亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2025 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3